The Ruhr University Bochum is a public research university located in the southern hills of the central Ruhr area, Bochum, Germany. It was founded in 1962 as the first new public university in Germany after World War II. Instruction began in 1965.

During the past decade, Department of Obstetrics and Gynecology of the Ruhr University Bochum conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 2 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Obstetrics and Gynecology of the Ruhr University Bochum" #1 sponsor was "Ruhr University of Bochum" with 15 trials, followed by "Zydolab - Institute of Cytology and Immune Cytochemistry" with 9 trials sponsored, "Corcym S.r.l" with 2 trials sponsored, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials sponsored and "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Obstetrics and Gynecology of the Ruhr University Bochum" #1 collaborator was "Ruhr University of Bochum" with 6 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Department of Obstetrics and Gynecology of the Ruhr University Bochum" are "Uterine Cervical Dysplasia" (9 trials), "Acute Myeloid Leukemia" (2 trials), "Aortic Valve Replacement" (2 trials), "Cervical Dysplasia" (2 trials) and "Cholangiocarcinoma" (2 trials). Many other conditions were trialed in "Department of Obstetrics and Gynecology of the Ruhr University Bochum" in a lesser frequency.

Most popular intervention types in "Department of Obstetrics and Gynecology of the Ruhr University Bochum" are "Device" (10 trials), "Drug" (9 trials), "Other" (9 trials), "Procedure" (9 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Capnography" (2 trials), "Placebo" (2 trials), "ADHD" (1 trials), "AG-120" (1 trials) and "AG-221" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Obstetrics and Gynecology of the Ruhr University Bochum" are 29 trials for "All" genders and 14 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Obstetrics and Gynecology of the Ruhr University Bochum". undefined are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in Department of Obstetrics and Gynecology of the Ruhr University Bochum, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Obstetrics and Gynecology of the Ruhr University Bochum, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 18 trials that are defined as “Not Applicable".

Department of Obstetrics and Gynecology of the Ruhr University Bochum has several departments that took part in Clinical trials: "Bergmannsheil, department for pain management" - 5 trials